Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed Study

This study has been completed.
Information provided by (Responsible Party):
Ranbaxy Inc. ( Ranbaxy Laboratories Limited ) Identifier:
First received: June 21, 2012
Last updated: July 28, 2012
Last verified: June 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2009
  Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)